Toggle navigation
Home
Search
Services
Blog
Contact
About
Prechronic Toxicity Studies of Carisprodol
Mulligan, Louis T.
Microbiological Associates, Inc., Rockville, MD, United States
Search 62 grants from Louis Mulligan
Search grants from Microbiological Associates, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Reactive oxygen species and respiratory muscle dysfunction in heart failure
Research Project 3: siRNA Therapy and Small Molecule Combination Treatment for Filoviruses
Multiscale Imaging of Spontaneous Activity in Cortex: Mechanisms, Development and Function
Stem Cell Therapy
Receptor Interaction with Gtp Regulatory Proteins
Recently added grants:
National Neuropsychological Network (NNN)
Insular Cortex and Social Affect
Functional analysis of autism risk genes during neural development using single cell seq
The Role of Neuronal Ensembles Supporting Auditory Fear Conditioning (Engrams) in the Amygdala in Memory Formation, Generalization and Extinction
Severe Maternal Morbidity: An Investigation of Racial-Ethnic Disparities, Social Disadvantage & Maternal Weight
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research and Development Contracts (N01)
Project #
N01ES075179-000
Application #
2310693
Study Section
Project Start
1987-03-03
Project End
Budget Start
1987-03-03
Budget End
1988-07-19
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Microbiological Associates, Inc.
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20850
Related projects
NIH 1987
N01 ES
Prechronic Toxicity Studies of Carisprodol
Mulligan, Louis T. / Microbiological Associates, Inc.
NIH 1987
N01 ES
Prechronic Toxicity Studies of Carisprodol
Mulligan, Louis T. / Microbiological Associates, Inc.
Comments
Be the first to comment on Louis Mulligan's grant